|
Market Closed -
Nasdaq
00:00:00 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.700 USD | +3.45% |
|
-9.28% | +12.69% |
| 11-06 | Verastem, Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 11-06 | RBC Cuts Price Target on Verastem to $18 From $19, Keeps Outperform, Speculative Risk | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.1B | - | - | - | ||
| 68.22B | |||||
| 59.82B | |||||
| 56.07B | |||||
| 47.67B | |||||
| 45.95B |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
